So a few words about BioNTech. We are a clinical -- late-stage clinical company with multiple programs in oncology, which is our core focus, but we have also both pipeline in infectious diseases, ...

Microsoft has seen a variety of executives leave in 2025, including a retired president, a devices corporate vice president ...